Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That 75% gain is very indicative somebody knows something.
"How's work Fred?"
"Well, lemme tell ya,,,"
I couldn't open it.
Give me the 5 cent tour :)
GMI-1070 (rivipansel) Phase 3 data due second half of 2019. Possibly July, or August.
EDP 305 Argon 1 Phase 2 initial Dara due 3q 2019
Phase 2 results reported this coming Thursday on July 18th.
That's all we can do.
A few catalysts are coming up.
This is brutal
Exactamundo
As a Roxor owner and seeing the popularity of Roxors, I stopped by to check the stock out.
Seems it should have far more growth than it has.
This is, imo, the best low cost index fund.
Heck, THE BEST index fund as it beats to he pricey funds.
Just keep track of trends, take profits, etc
Use you as my punching bag?
What are you talking about?
I was asking about the potential gain upon uplisting and not directed to anyone in particular.
That's what I'm using as a gage.
Even a few dollars would be nice.
I hope so.
I'm to far in to bail.
They bought in at 1.20 or above.
Now we are at .40
Is a 200% gain with the future uplisting feasible?
That's my concern.
Oh well, any gain will take away some of the sting.
Zygel has been designated a Fast Track development program by the U.S. Food and Drug Administration for treatment of behavioral symptoms of FXS. Enrollment is ongoing in CONNECT-FX, a multi-national, randomized, double blind placebo controlled pivotal clinical trial of Zygel in FXS (https://www.connectfxtrial.com/); topline data are expected in the second half of 2019. Additionally, Zynerba expects topline data from its Phase 2 open label BELIEVE 1 trial of Zygel in developmental and epileptic encephalopathies (DEE) in the third quarter of 2019. Zynerba has also initiated the Phase 2 BRIGHT trial in Autism Spectrum Disorder and the Phase 2 INSPIRE trial in 22q11.2 Deletion Syndrome, with data expected from both studies in the first half of 2020.
Not many, if any big mouth pumpers on this board,, thank God.
We try to stick with facts.
I hate pumpers and dumpers, I hope they stay away.
Teladoc blows away SOLI,, so far.
Just compare them in the past month.
I hope SOLI uplists, but a 30% uptick will bring me back to even.
I think ZYNE beats the other Cannabis stocks.
Just look at the chart for the past three months and compare to the growers and CBDers.
Sorry I triggered you.
But a huge drop in the past three weeks brings out my sarcasm.
Sorry you don't understand.
1.3 to 0.45 ,,,, exciting times *eyes rolling*
When, and if this uplist happens, I might break even.
I have no idea who the moderators are.
Long and Strong.
Are you talking about GEQU?
Gotcha.
Interesting.
Im in with one share.
First time Iv ever only bought one share of a penny stock.
Then why not buy 10? or 20, or 100?
Yeah, never read into any pump or dump when they do not explain their 'enthusiasm'.
Link please because the chart is not reflecting that.
If it does upgrade, I may break even unless it sinks further.
Somebody dumped, so I added.
Ignore my previous post.
It was supposed to be on the priority review coming up in September.
Vascepa.
PDUFA date under priority review September 28, 2019
I never said it wasn't.
I just said I watched it sail past me the other day.
In other words, I missed out.
I put this on my 'watch' list and watched it sail without me,,, *sigh*
I know you won't :)
Love this stock.
Nothing but positives.
Clay likes to flip.
I highly recommend you do not take that risk.
Looks like the data was okay, but not great.
Really?
LOL!
Phase 1 data to be presented on July 5th at ESMO.
There colorectal cancer drug.
Looks like a Grand Tetons day.
That's okay, getting lots of attention.
Let's hope it ends on top of Grand Teton peak.
That's right,, get up there!
LOL
Yes, I heard about an Uber driver who attemped to assault a female passenger.
Unfortunately his record was clean and he had proof of insurance.